Precision medicine
No approved commercial tests are available, and processing the emergency-use tests FDA temporarily authorized takes too long and raises concerns about accuracy. Researchers are working to streamline that process.
The second Pop Health Forum 2016 took place in Chicago with expert speakers, panelists and healthcare professionals discussing pressing issues, from analytics to chronic care management to telehealth. Here’s a roundup of what happened.
The deal marks the first testing collaboration for Intermountain Precision Genomics outside of the U.S.
The technology leverages the company’s 175 million patient-record years and a patient’s medical history to predict the patient’s future health.
The $8.2 million deal with Moderna aims to accelerate the development of vaccine technology and is expected to be faster than other approaches in developing vaccines.
MIT professor John Guttag said that growing sets of aggregated data, federal rules mandating access to information and existing tools make machine learning a reality today. Here’s what healthcare organizations need to know about the emerging technology.
These approaches have enormous potential to enable clinicians, doctors and researchers to spot patterns in existing data sets. We take a look at the two styles and what they mean to healthcare organizations.
The funding will help speed the development of a new test that uses digital images of a biopsy slide to detect Barrett’s Esophagus, a condition that can lead to cancer, the companies said.
A team at Houston Methodist believes it has developed an artificial intelligence software program that can improve mammography readings to 99 percent accuracy by analyzing the free form text of clinical reports.
The top reason for using advanced analytics, especially within population health programs, is enabling interventions that prevent health declines, respondents said.